Evidence map›Paper›PMID 32850725›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Ankita Chopra, Shishir Bobate, Praveen Rahi, Arun Banpurkar, Pranab Behari Mazumder, Surekha Satpute

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Enhanced Fermentation of Pu-Erh Tea withMolecules (Basel, Switzerland) · 2024
    Article
  5. A Novel StrainCells · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Frontiers in plant science · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Characterization and Cytotoxicity ofFrontiers in bioengineering and biotechnology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ankita ChopraDepartment of Biotechnology, Assam University, Silchar, India.
Shishir BobateDepartment of Microbiology, Savitribai Phule Pune University, Pune, India.
Praveen RahiNational Centre for Microbial Resource, National Centre for Cell Science, Pune, India.
Arun BanpurkarDepartment of Physics, Savitribai Phule Pune University, Pune, India.
Pranab Behari MazumderDepartment of Biotechnology, Assam University, Silchar, India.
Surekha SatputeDepartment of Microbiology, Savitribai Phule Pune University, Pune, India.
Savitribai Phule Pune University · INAssam University · INNational Centre for Cell Science · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tea is an ancient non-alcoholic beverage plantation crop cultivated in the most part of Assam, India. Being a long-term monoculture, tea plants are prone to both biotic and abiotic stresses, and requires massive amounts of chemicals as fertilizers and pesticides to achieve worthy crop productivity. The rhizosphere bacteria with the abilities to produce phytohormone, secreting hydrolytic enzyme, biofilm formation, bio-control activity provides induced systemic resistance to plants against pathogens. Thus, plant growth promoting (PGP) rhizobacteria represents as an alternative candidate to chemical inputs for agriculture sector. Further, deciphering the secondary metabolites, including biosurfactant (BS) allow developing a better understanding of rhizobacterial strains. The acidic nature of tea rhizosphere is predominated by

Indexed as

biosurfactantPGPRPseudomonassurface tensiontea

Identifiers

PMID32850725
PMCPMC7403194
OpenAlexW3045680684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.